MD Stock Recent News
MD LATEST HEADLINES
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2024 Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy James Swift - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer and Treasure Conference Call Participants Jack Senft - William Blair Jack Slevin - Jefferies A.J. Rice - UBS Operator Ladies and gentlemen, thank you for standing by and welcome to the 2024 Third Quarter's Earnings Conference.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.32 per share a year ago.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2024 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2024.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and Revvity (RVTY). But which of these two stocks presents investors with the better value opportunity right now?
Pediatrix Medical Group (MD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.